GSK PLC (LSE:GSK)
£ 13.97 0.16 (1.16%) Market Cap: 57.00 Bil Enterprise Value: 69.85 Bil PE Ratio: 22.90 PB Ratio: 4.07 GF Score: 69/100

Q4 2023 GSK plc Earnings Call Transcript

Jan 31, 2024 / 11:00AM GMT
Release Date Price: £15.68 (+1.96%)
Nick Stone

Hello, everyone. It's Nick Stone, Head of Investor Relations. Welcome to today's call and webcast. The presentation was sent to our distribution list by e-mail, and you can also find it on gsk.com.

Please turn to Slide 2. This is the usual safe harbor statement. We will comment on our performance using constant exchange rates, or CR unless stated otherwise. As a reminder, following the Consumer Healthcare demerger in 2022, we're presenting performance and growth at the continuing operations for GSK.

Please turn to Slide 3. Today's call will last approximately 1 hour with the presentation taking around 30 minutes and the remaining time for your questions. We request that you ask 1 to 2 questions so that everyone has a chance to participate.

Turning to Slide 4. I will now hand the call over to Emma.

Emma Natasha Walmsley
GSK plc - CEO & Director

Hello, and a warm welcome to everybody joining this call. Today, we are updating you on our performance for 2023, giving guidance for 2024, and providing you with new upgraded longer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot